Stroke Clinical Trials

Find Stroke Clinical Trials Near You

Effects of Contralateral Gravity Eliminated Gluteus Medius and Ipsilateral Quadratus Lumborum Strengthening on Pelvic Alignment, Balance and Functional Mobility on Subacute Stroke Patients

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to compare the effects of contralateral gravity-eliminated gluteus medius strengthening and ipsilateral quadratus lumborum strengthening, both combined with conventional physiotherapy, on pelvic alignment, balance, and functional mobility in patients with subacute stroke. This single-blinded, two-arm, parallel-group randomized clinical trial will be conducted at the Department of Physical Therapy Rehabilitation, Alfalah Medical Center, Lahore, Pakistan. A total of 40 participants aged 45-60 years with a first-ever stroke occurring 1-6 months before enrollment will be recruited and randomly allocated to two groups. Group A will receive 30 minutes of conventional physiotherapy followed by 20 minutes of contralateral gravity-eliminated gluteus medius strengthening, while Group B will receive 30 minutes of conventional physiotherapy followed by 20 minutes of ipsilateral quadratus lumborum strengthening. Both groups will receive treatment three times per week for six weeks. The primary outcome measures will include pelvic alignment assessed using the Palpation Meter (PALM), balance assessed using the Berg Balance Scale (BBS), and functional mobility assessed using the Timed Up and Go (TUG) test. All outcome measures will be assessed at baseline, immediately after the six-week intervention, and at week 12 to evaluate changes following treatment and at follow-up. The study will compare outcomes between the two groups to determine the relative effectiveness of the two targeted strengthening approaches when combined with conventional physiotherapy in patients with subacute stroke.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Maximum Age: 65
Healthy Volunteers: f
View:

• Patients aged 45-65 years. Patients with a first-ever stroke occurring 1-6 months before enrollment (subacute stroke).

• Patients classified within Brunnstrom Recovery Stages III-V. Medically stable patients who are able to follow simple verbal commands. Patients able to stand independently or with minimal assistance. Patients with a Berg Balance Scale (BBS) score below 45 out of 56.

Locations
Other Locations
Pakistan
Alfalah Medical Center
RECRUITING
Lahore
Contact Information
Primary
Prof.Dr Shoaib Waqas, PHD
shoaib.waqas@ubas.edu.pk
+92 302 4552109
Time Frame
Start Date: 2026-08-15
Estimated Completion Date: 2027-01-30
Participants
Target number of participants: 40
Treatments
Experimental: Experimental: Contralateral Gravity-Eliminated Gluteus Medius Strengthening Group
Group A participants will receive conventional physiotherapy combined with contralateral gravity-eliminated gluteus medius strengthening for six weeks. Each session will include 30 minutes of conventional physiotherapy and 20 minutes of targeted gluteus medius strengthening. Sessions will be conducted three times per week for six weeks, for a total of 18 supervised sessions. The program will focus on improving gluteus medius activation, pelvic control, and lumbopelvic stability through supported gravity-eliminated exercises.
Active_comparator: Quadratus Lumborum Strengthening Group
Group B participants will receive conventional physiotherapy combined with ipsilateral quadratus lumborum strengthening for six weeks. Each session will include 30 minutes of conventional physiotherapy and 20 minutes of targeted quadratus lumborum strengthening. Sessions will be conducted three times per week for six weeks, for a total of 18 supervised sessions. The program will focus on improving quadratus lumborum activation, trunk stability, and pelvic control.
Related Therapeutic Areas
Sponsors
Leads: Lahore University of Biological and Applied Sciences

This content was sourced from clinicaltrials.gov